<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02160184</url>
  </required_header>
  <id_info>
    <org_study_id>NIGHT CONTROL</org_study_id>
    <nct_id>NCT02160184</nct_id>
  </id_info>
  <brief_title>Nocturnal Insulin-Glucose in Hospital: Tight Control</brief_title>
  <acronym>NIGHT CONTROL</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the efficacy and safety of a closed-loop system consisting
      of a predictive rule-based algorithm integrated on the Medtronic Portable Glucose Control
      System (PGCS) in patients with type 1 diabetes for controlling the nocturnal and
      post-breakfast periods. Intervention will be to apply the automated closed-loop system by
      administering a subcutaneous insulin microbolus every 5 minutes depending on reading from a
      continuous glucose measurement (CGM) system.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of time in target range (3.9-8.0 mmol/l) YSI glucose during the in clinic overnight visit.</measure>
    <time_frame>During the closed-loop period for each patient: 12 hours</time_frame>
  </primary_outcome>
  <enrollment>12</enrollment>
  <condition>Type 1 Diabetes</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Artificial pancreas system consisting of a predictive rule-based algorithm integrated on the Medtronic Portable Glucose Control System (PGCS)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 Diabetes

          -  Diabetes duration &gt; 3 years

          -  Continuous Subcutaneous Insulin Infusion (CSII) treatment for more than 1 year

          -  A1c 6-9%

          -  No ketoacidosis during the previous 12 months

          -  Glomerular Filtration Rate (GFR) &gt; 60 ml/kg/min m2

          -  Willingness of participate and signed and dated written informed consent in accordance
             with Good Clinical Practice

        Exclusion Criteria:

          -  Gastroparesis

          -  Hypoglycemia unawareness

          -  Uncorrected visual impairment

          -  Deafness

          -  BMI&gt; 35 kg/m2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mercedes Rigla, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Parc Tauli University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mercedes Rigla, MD, PhD</last_name>
    <phone>+34 93 745 84 12</phone>
    <email>mrigla@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Parc Tauli University Hospital</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mercedes Rigla, MD, PhD</last_name>
      <phone>+34 93 745 84 12</phone>
      <email>mrigla@tauli.cat</email>
    </contact>
    <investigator>
      <last_name>Mercedes Rigla, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2014</study_first_submitted>
  <study_first_submitted_qc>June 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2014</study_first_posted>
  <last_update_submitted>June 9, 2014</last_update_submitted>
  <last_update_submitted_qc>June 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Mercedes Rigla</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

